Jacobson Center for Clinical & Translational Research

Studies at UToledo: Neurology

 

Epilepsy

Study Title:  A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures (REALIZE Trial)

+ More Info

 

Huntington's Disease

There are no studies in this area currently

Parkinson's

Study Title:  Phase 3, Double-Blind, Randomized, Placebo‑Controlled, Parallel ‑ Group, 27‑Week Study of the Efficacy, Safety, and Tolerability of Two Fixed Doses of Tavapadon in Early Parkinson’s Disease

+ More Info

Study Title:  A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Flexible-Dose, 27-Week Trial to Evaluate the Efficacy, Safety, and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults With Motor Fluctuations (TEMPO-3 Trial)

+ More Info

Study Title:  Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment of Dyskinesia in Patients with Parkinson's Disease Receiving Levodopa-based Therapy With or Without Concomitant Dopaminergic Medications

+ More Info

Study Title:  58-Week Open-label Trial of Tavapadon in Parkinson's Disease (TEMPO-4 Trial)

+ More Info

Study Title:  A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's Disease (PD) Participants Treated With Carbidopa/Levodopa and NE3107

+ More Info

Last Updated: 8/11/22